AAAAAA
Results:
1-25
|
Results: 25
Authors:
FESER W
KERDAR RS
BAUMANN A
KORBER J
BLODE H
KUHNZ W
Citation: W. Feser et al., DNA ADDUCT FORMATION OF SELECTED SEX STEROIDS IN HUMAN LIVER SLICES IN-VITRO, Toxicology in vitro, 12(4), 1998, pp. 353
Authors:
KUHNZ W
GIESCHEN H
Citation: W. Kuhnz et H. Gieschen, PREDICTING THE ORAL BIOAVAILABILITY OF 19-NORTESTOSTERONE PROGESTINS IN-VIVO FROM THEIR METABOLIC STABILITY IN HUMAN LIVER MICROSOMAL PREPARATIONS IN-VITRO, Drug metabolism and disposition, 26(11), 1998, pp. 1120-1127
Authors:
KUHNZ W
KULMANN H
FUHRMEISTER A
Citation: W. Kuhnz et al., INVESTIGATION INTO THE AGE-DEPENDENCE OF THE PHARMACOKINETICS OF CYPROTERONE-ACETATE IN HEALTHY MALE-VOLUNTEERS, European Journal of Clinical Pharmacology, 53(1), 1997, pp. 75-80
Authors:
KUHNZ W
HEUNER A
HUMPEL M
SEIFERT W
MICHAELIS K
Citation: W. Kuhnz et al., IN-VIVO CONVERSION OF NORETHISTERONE AND NORETHISTERONE ACETATE TO ETHINYL ESTRADIOL IN POSTMENOPAUSAL WOMEN, Contraception, 56(6), 1997, pp. 379-385
Authors:
BAUMANN A
KERDAR RS
CRAMER P
FESER W
BLODE H
SALOMON A
KUHNZ W
Citation: A. Baumann et al., USE OF RAT AND HUMAN LIVER SLICES FOR THE DETECTION OF STEROID HORMONE-INDUCED DNA-ADDUCTS IN-VITRO BY MEANS OF THE P-32 POSTLABELING TECHNIQUE, Pharmacology & toxicology, 78(4), 1996, pp. 214-223
Authors:
KUHNZ W
HUMPEL M
BIERE H
GROSS D
Citation: W. Kuhnz et al., INFLUENCE OF REPEATED ORAL DOSES OF ETHINYLESTRADIOL ON THE METABOLICDISPOSITION OF [C-13(2)]-ETHINYLESTRADIOL IN YOUNG-WOMEN, European Journal of Clinical Pharmacology, 50(3), 1996, pp. 231-235
Authors:
BAUMANN A
FUHRMEISTER A
BRUDNYKLOPPEL M
DRAEGER C
BUNTE T
KUHNZ W
Citation: A. Baumann et al., COMPARATIVE PHARMACOKINETICS OF 2 NEW STEROIDAL ESTROGENS AND ETHINYLESTRADIOL IN POSTMENOPAUSAL WOMEN, Contraception, 54(4), 1996, pp. 235-242
Authors:
BAUMANN A
KULMANN H
GORKOV V
MAHLER M
KUHNZ W
Citation: A. Baumann et al., RADIOIMMUNOLOGICAL ANALYSIS OF CYPROTERONE-ACETATE IN HUMAN SERUM - COMPARISON WITH A GAS-CHROMATOGRAPHIC MASS-SPECTROMETRIC METHOD AND INFLUENCE OF EACH METHOD ON THE OUTCOME OF A BIOEQUIVALENCE TRIAL, Arzneimittel-Forschung, 46(4), 1996, pp. 412-418
Authors:
KUHNZ W
LOFBERG B
Citation: W. Kuhnz et B. Lofberg, URINARY-EXCRETION OF 6-BETA-HYDROXYCORTISOL IN WOMEN DURING TREATMENTWITH DIFFERENT ORAL-CONTRACEPTIVE FORMULATIONS, Journal of steroid biochemistry and molecular biology, 55(1), 1995, pp. 129-133
Authors:
HEUNER A
KUHNZ W
HEGERMAHN D
RICHERT K
HUMPEL M
Citation: A. Heuner et al., A SINGLE-DOSE AND 3-MONTH CLINICAL-PHARMACOKINETIC STUDY WITH A NEW COMBINATION ORAL-CONTRACEPTIVE, Advances in contraception, 11(3), 1995, pp. 207-225
Authors:
KERDAR RS
BAUMANN A
BRUDNYKLOPPEL M
BIERE H
BLODE H
KUHNZ W
Citation: Rs. Kerdar et al., IDENTIFICATION OF 3-ALPHA-HYDROXY-CYPROTERONE ACETATE AS A METABOLITEOF CYPROTERONE-ACETATE IN THE BILE OF FEMALE RATS AND THE POTENTIAL OF THIS AND OTHER ALREADY KNOWN OR PUTATIVE METABOLITES TO FORM DNA-ADDUCTS IN-VITRO, Carcinogenesis, 16(8), 1995, pp. 1835-1841
Authors:
BALOGH A
KLINGER G
HENSCHEL L
BORNER A
VOLLANTH R
KUHNZ W
Citation: A. Balogh et al., INFLUENCE OF ETHINYLESTRADIOL-CONTAINING COMBINATION ORAL-CONTRACEPTIVES WITH GESTODENE OR LEVONORGESTREL, European Journal of Clinical Pharmacology, 48(2), 1995, pp. 161-166
Authors:
KUHNZ W
LOUTON T
HUMPEL M
BACK DJ
ZAMAH NM
Citation: W. Kuhnz et al., INFLUENCE OF HIGH-DOSES OF VITAMIN-C ON THE BIOAVAILABILITY AND THE SERUM-PROTEIN BINDING OF LEVONORGESTREL IN WOMEN USING A COMBINATION ORAL-CONTRACEPTIVE, Contraception, 51(2), 1995, pp. 111-116
Authors:
KUHNZ W
FRITZEMEIER KH
HEGELEHARTUNG C
KRATTENMACHER R
Citation: W. Kuhnz et al., COMPARATIVE PROGESTATIONAL ACTIVITY OF NORGESTIMATE, LEVONORGESTREL-OXIME AND LEVONORGESTREL IN THE RAT AND BINDING OF THESE COMPOUNDS TO THE PROGESTERONE-RECEPTOR, Contraception, 51(2), 1995, pp. 131-139
Authors:
KUHNZ W
SCHUTT B
WOLOSZCZAK R
Citation: W. Kuhnz et al., INFLUENCE OF CHANGES IN THE CONCENTRATION OF SEX HORMONE-BINDING GLOBULIN IN HUMAN SERUM ON THE PROTEIN-BINDING OF THE CONTRACEPTIVE STEROIDS LEVONORGESTREL, 3-KETO-DESOGESTREL AND GESTODENE, Journal of steroid biochemistry and molecular biology, 48(5-6), 1994, pp. 573-580
Authors:
KUHNZ W
HOYER GA
BACKHUS S
JAKOBS U
Citation: W. Kuhnz et al., METABOLISM OF THE STEROIDAL AROMATASE INHIBITOR ATAMESTANE IN RATS, CYNOMOLGUS MONKEYS AND HUMANS - ISOLATION AND IDENTIFICATION OF THE MAJOR METABOLITES, European journal of drug metabolism and pharmacokinetics, 19(2), 1994, pp. 137-150
Authors:
LOUTON T
KUHNZ W
DIBBELT L
KNUPPEN R
Citation: T. Louton et al., WEIGHTED SERUM POOLS IN COMPARISON TO THE TRAPEZOIDAL RULE FOR ESTIMATING AUCS FOR ETHINYL ESTRADIOL - THE RELATIONSHIP OF THE VARIANCE OF THE DETERMINATION TO THE INTERINDIVIDUAL VARIANCE, European Journal of Clinical Pharmacology, 46(1), 1994, pp. 77-81
Authors:
KUHNZ W
STAKS T
JUTTING G
Citation: W. Kuhnz et al., PHARMACOKINETICS OF LEVONORGESTREL AND ETHINYLESTRADIOL IN 14 WOMEN DURING 3 MONTHS OF TREATMENT WITH A TRI-STEP COMBINATION ORAL-CONTRACEPTIVE - SERUM-PROTEIN BINDING OF LEVONORGESTREL AND INFLUENCE OF TREATMENT ON FREE AND TOTAL TESTOSTERONE LEVELS IN THE SERUM, Contraception, 50(6), 1994, pp. 563-579
Authors:
KUHNZ W
BLODE H
MAHLER M
Citation: W. Kuhnz et al., SYSTEMIC AVAILABILITY OF LEVONORGESTREL AFTER SINGLE ORAL-ADMINISTRATION OF A NORGESTIMATE-CONTAINING COMBINATION ORAL-CONTRACEPTIVE TO 12 YOUNG-WOMEN, Contraception, 49(3), 1994, pp. 255-263
Authors:
KUHNZ W
BEIER S
Citation: W. Kuhnz et S. Beier, COMPARATIVE PROGESTATIONAL AND ANDROGENIC ACTIVITY OF NORGESTIMATE AND LEVONORGESTREL IN THE RAT, Contraception, 49(3), 1994, pp. 275-289
Authors:
KUHNZ W
STAKS T
JUTTING G
Citation: W. Kuhnz et al., PHARMACOKINETICS OF CYPROTERONE-ACETATE AND ETHINYLESTRADIOL IN 15 WOMEN WHO RECEIVED A COMBINATION ORAL-CONTRACEPTIVE DURING 3 TREATMENT CYCLES, Contraception, 48(6), 1993, pp. 557-575
Authors:
LEHMANN R
BHARGAVA AS
KUHNZ W
FREIHUBE G
GUNZEL P
Citation: R. Lehmann et al., EFFECT OF NORETHISTERONE ACETATE ON SERUM-LIPID AND LIPOPROTEIN PARAMETERS AS WELL AS ON BLOOD-COAGULATION IN FEMALE MONKEYS (MACACA-FASCICULARIS), Contraception, 48(6), 1993, pp. 576-590
Authors:
KUHNZ W
BAUMANN A
STAKS T
DIBBELT L
KNUPPEN R
JUTTING G
Citation: W. Kuhnz et al., PHARMACOKINETICS OF GESTODENE AND ETHINYLESTRADIOL IN 14 WOMEN DURING3 MONTHS OF TREATMENT WITH A NEW TRI-STEP COMBINATION ORAL-CONTRACEPTIVE - SERUM-PROTEIN BINDING OF GESTODENE AND INFLUENCE OF TREATMENT ONFREE AND TOTAL TESTOSTERONE LEVELS IN THE SERUM, Contraception, 48(4), 1993, pp. 303-322
Authors:
ZAMAH NM
HUMPEL M
KUHNZ W
LOUTON T
RAFFERTY J
BACK DJ
Citation: Nm. Zamah et al., ABSENCE OF AN EFFECT OF HIGH VITAMIN-C DOSAGE ON THE SYSTEMIC AVAILABILITY OF ETHINYL ESTRADIOL IN WOMEN USING A COMBINATION ORAL-CONTRACEPTIVE, Contraception, 48(4), 1993, pp. 377-391
Authors:
KUHNZ W
GANSAU C
MAHLER M
Citation: W. Kuhnz et al., PHARMACOKINETICS OF ESTRADIOL, FREE AND TOTAL ESTRONE, IN YOUNG-WOMENFOLLOWING SINGLE INTRAVENOUS AND ORAL-ADMINISTRATION OF 17-BETA-ESTRADIOL, Arzneimittel-Forschung, 43-2(9), 1993, pp. 966-973
Risultati:
1-25
|